Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma

類似資料

• S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
  著者:: Wagner, Nikolaus B, 等
  出版事項: (2018)
• BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy
  著者:: Meckbach, Diana, 等
  出版事項: (2014)
• Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
  著者:: Annette Pflugfelder, 等
  出版事項: (2011-01-01)
• Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma
  著者:: Pflugfelder, Annette, 等
  出版事項: (2011)
• The need for psycho-oncological support for melanoma patients: Central role of patients’ self-evaluation
  著者:: Mayer, Simone, 等
  出版事項: (2017)